Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
524804
Company
AUROBINDO PHARMA LTD.
Exchange Received Time
07/09/2020 18:35:08
Exchange Disseminated Time
07/09/2020 18:35:16
Time Taken
00:00:08
Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
09/07/20 18:35
Owing to changes in the business dynamics, the Restructuring Committee of Board of Directors of the Company at its meeting held today, September 7, 2020 has considered and approved modifications to the aforesaid Scheme pursuant to sections 230-232 and other applicable provisions of the Companies Act, 2013, whereby APL Healthcare Limited, a wholly owned subsidiary of the Company & Transferor Company 6, would be excluded from the Scheme and will accordingly, modify the Scheme and continue with the modified Scheme of Amalgamation of its wholly owned subsidiaries viz., APL Research Centre Limited and Aurozymes Limited and Curepro Parenteral Limited and Hyacinths Pharma Private Limited and Silicon Life Sciences Private Limited with Aurobindo Pharma Limited (Transferee Company). The modified Scheme would be subject to the requisite statutory / regulatory approvals including the approval of the Hon'ble National Company Law Tribunal, Bench at Hyderabad.
Attachment
<< Back
Recently Viewed